# ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)

> **NCT03654001** · PHASE3 · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 1319 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **BIOLOGICAL:** Albumin
- **OTHER:** Balanced

## Key facts

- **NCT ID:** NCT03654001
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-07
- **Primary completion:** 2024-10-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 1319 (ACTUAL)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654001, "ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03654001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*